Regenerex Pharma (RGPX) Change in Cash (2012 - 2025)

Regenerex Pharma (RGPX) has 12 years of Change in Cash data on file, last reported at -$160771.0 in Q3 2025.

• Change in Cash for Q3 2025 came in at -$160771.0, down 54784.01% year-over-year; the trailing twelve-month figure through Sep 2025 was $11365.0 (up 296.42% YoY), and the FY2025 annual result was $652653.0, up 85637.75% from the prior year.
• Change in Cash improved to -$160771.0 in Q3 2025 per RGPX's latest filing, from -$480595.0 in the prior quarter.
• Over five years, Change in Cash peaked at $652687.0 in Q1 2025 and troughed at -$480595.0 in Q2 2025.
• A 5-year average of $264.28 and a median of -$260.5 in 2022 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 8821.1% in 2025 and fell as far as 129092.2% in 2025.
• A 5-year view of Change in Cash shows it stood at $244.0 in 2021, then jumped by 135.25% to $574.0 in 2022, then surged by 209.41% to $1776.0 in 2023, then plunged by 97.52% to $44.0 in 2024, then sank by 365488.64% to -$160771.0 in 2025.
• Business Quant data shows RGPX's Change in Cash at -$160771.0 in Q3 2025, -$480595.0 in Q2 2025, and $652687.0 in Q1 2025.